The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $137,333 were sold by MACARTNEY LAWSON on Nov 08 ’24. At $68.67 per share, MACARTNEY LAWSON sold 2,000 shares. The insider’s holdings dropped to 47,965 shares worth approximately $2.47 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, LAWSON MACARTNEY purchased 2,000 shares, netting a total of over 137,333 in proceeds.
Before that, ZANTE GREG had sold 131,687 shares from its account. In a trade valued at $10,089,164, the Chief Financial Officer traded Viking Therapeutics Inc shares for $76.61 each. Upon closing the transaction, the insider’s holdings decreased to 131,687 shares, worth approximately $7.7 million.
As published in a research note from H.C. Wainwright on November 04, 2024, Viking Therapeutics Inc [VKTX] has been retained to a Buy and the price target has been revised to $102. Analysts at JP Morgan started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of June 27, 2024, Morgan Stanley has initiated its “an Overweight” rating for VKTX. Earlier on May 16, 2024, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for VKTX stock which previously was a “an Outperform”.
Analyzing VKTX Stock Performance
During the last five days, there has been a drop of approximately -6.41%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 176.89%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $64.24, while a 200-day SMA reached $62.14. Nevertheless, trading volume fell to 3.5 million shares from 5.51 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 50.27, which, if violated, would cause prices to drop to 49.02. In the upper region, resistance lies at 52.91. The next price resistance is at 54.30. RSI (Relative Strength Index) is 35.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -9.12, which suggests the price will decrease in the coming days. Percent R is at 87.66%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
